Stay updated on Nivolumab and RT in Localized Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the study record of a phase II trial investigating the combination of nivolumab and radiation therapy in treating patients with urothelial bladder cancer who are ineligible for chemotherapy.
    Difference
    0.1%
    Check dated 2024-06-06T14:42:57.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    38%
    Check dated 2024-05-22T21:15:41.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:15:54.000Z thumbnail image

Stay in the know with updates to Nivolumab and RT in Localized Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.